Clinical Trials In Salt Lake

Discover hundreds of clinical trials in Salt Lake.
Search clinical trials in Salt Lake by condition or phase.

e.g. Respiratory Diseases

Salt Lake•Healthy volunteers: No

Filter results

Results: 1,146

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Salt Lake City, Los Angeles, Palo Alto, San Franciscoshow 6 more

Code:

NCT01196182

Conditions

Congenital Heart Defects

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Recruiting

Sponsor:

NIH

Location:

Salt Lake City, Los Angeles, Minneapolis

Code:

NCT01543620

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab Vs Pembrolizumab in First-line Treatment of Head and Neck Cancer

Recruiting

Phase 3

Sponsor:

Merus N.V.

Location:

Salt Lake City, Fort Myers, Orlando, Louisvilleshow 3 more

Code:

NCT06525220

Conditions

Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Petosemtamab

Pembrolizumab

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

Phase 3

Sponsor:

Novartis Pharmaceuticals

Location:

Salt Lake City, Phoenix, Scottsdale, Tucsonshow 60 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

Phase 2

Phase 3

Sponsor:

Regeneron Pharmaceuticals

Location:

West Jordan, Salt Lake City, Phoenix, Apple Valleyshow 40 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Salt Lake City, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

Phase 3

Sponsor:

Sanofi

Location:

Salt Lake City, Birmingham, Cullman, Phoenixshow 61 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

A Randomized Multicenter Study for Isolated Skin Vasculitis

Recruiting

Phase 2

Sponsor:

University of Pennsylvania

Location:

Salt Lake City, Kansas City, Boston, Rochestershow 8 more

Code:

NCT02939573

Conditions

Primary Cutaneous Vasculitis

Cutaneous Polyarteritis Nodosa

IgA Vasculitis

Henoch-Schönlein Purpura

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Colchicine

Dapsone

Azathioprine

Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome

Recruiting

Phase 3

Sponsor:

Syros Pharmaceuticals

Location:

Salt Lake City, Tucson, Irvine, Los Angelesshow 21 more

Code:

NCT04797780

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tamibarotene

Placebo

Azacitidine

IMPRoving Outcomes in Vascular DisEase- Aortic Dissection

Recruiting

Sponsor:

Duke University

Location:

Salt Lake City, Phoenix, Long Beach, Los Angelesshow 29 more

Code:

NCT06087029

Conditions

Type B Aortic Dissection

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

TEVAR

Guideline directed medical therapy and surveillance of dissection

e.g. Respiratory Diseases

Salt Lake•Healthy volunteers: No

Filter results

Results: 1,146

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Salt Lake City, Los Angeles, Palo Alto, San Franciscoshow 6 more

Code:

NCT01196182

Conditions

Congenital Heart Defects

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Recruiting

Sponsor:

NIH

Location:

Salt Lake City, Los Angeles, Minneapolis

Code:

NCT01543620

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab Vs Pembrolizumab in First-line Treatment of Head and Neck Cancer

Recruiting

Phase 3

Sponsor:

Merus N.V.

Location:

Salt Lake City, Fort Myers, Orlando, Louisvilleshow 3 more

Code:

NCT06525220

Conditions

Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Petosemtamab

Pembrolizumab

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

Phase 3

Sponsor:

Novartis Pharmaceuticals

Location:

Salt Lake City, Phoenix, Scottsdale, Tucsonshow 60 more

Code:

NCT05147220

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

Phase 2

Phase 3

Sponsor:

Regeneron Pharmaceuticals

Location:

West Jordan, Salt Lake City, Phoenix, Apple Valleyshow 40 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Salt Lake City, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

Phase 3

Sponsor:

Sanofi

Location:

Salt Lake City, Birmingham, Cullman, Phoenixshow 61 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

A Randomized Multicenter Study for Isolated Skin Vasculitis

Recruiting

Phase 2

Sponsor:

University of Pennsylvania

Location:

Salt Lake City, Kansas City, Boston, Rochestershow 8 more

Code:

NCT02939573

Conditions

Primary Cutaneous Vasculitis

Cutaneous Polyarteritis Nodosa

IgA Vasculitis

Henoch-Schönlein Purpura

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Colchicine

Dapsone

Azathioprine

Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome

Recruiting

Phase 3

Sponsor:

Syros Pharmaceuticals

Location:

Salt Lake City, Tucson, Irvine, Los Angelesshow 21 more

Code:

NCT04797780

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tamibarotene

Placebo

Azacitidine

IMPRoving Outcomes in Vascular DisEase- Aortic Dissection

Recruiting

Sponsor:

Duke University

Location:

Salt Lake City, Phoenix, Long Beach, Los Angelesshow 29 more

Code:

NCT06087029

Conditions

Type B Aortic Dissection

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

TEVAR

Guideline directed medical therapy and surveillance of dissection